Professor Tony Schapira (UCL Clinical Neuroscience) and Dr
Stephen Mullin (UCL Institute of Neurology) explain how a rare genetic condition called Gaucher
disease may hold the key
to discovering a drug that slows or stops the progress of Parkinson's disease.
Read: Jewish Chronicle
Close
